Methylamine → (S)-1-(3-aminomethyl-1,2,4-oxadiazol-5-yl)-7-fluoro-12,12a-dihydro-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepin-9-one
反応式
[F:1][C:2]1[CH:3]=[CH:4][C:5]2[N:11]3[CH:12]=[N:13][C:14]([C:15]4[O:19][N:18]=[C:17]([CH2:20][N:21]5C(=O)C6=CC=CC=C6C5=O)[N:16]=4)=[C:10]3[C@@H:9]3[CH2:32][CH2:33][N:8]3[C:7](=[O:34])[C:6]=2[CH:35]=1.CN>C(O)C>[NH2:21][CH2:20][C:17]1[N:16]=[C:15]([C:14]2[N:13]=[CH:12][N:11]3[C:5]4[CH:4]=[CH:3][C:2]([F:1])=[CH:35][C:6]=4[C:7](=[O:34])[N:8]4[CH2:33][CH2:32][C@H:9]4[C:10]=23)[O:19][N:18]=1参加物
反応物 2
生成物 1
試薬・触媒・溶媒 1
実験手順
10.8 g (23 mmol) of crude (S)-7-fluoro-12,12a-dihydro-1-(3-phthalimidomethyl-1,2,4-oxadiazol-5-yl)-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepin-9-one in 150 ml of ethanol were treated dropwise with 150 ml of methylamine (33% in ethanol) at 60° C. within 30 min. The solution was stirred at 70° for 2 hours and subsequently concentrated. The residue was taken up in methylene chloride and 30 ml of 4N hydrochloric acid and the solution was washed three times with methylene chloride. The aqueous phase was made alkaline with 30 ml of 4N sodium hydroxide solution and extracted five times with methylene chloride. After drying the combined organic solutions and evaporating the solvent there were obtained 7.5 g (96%) of (S)-1-(3-aminomethyl-1,2,4-oxadiazol-5-yl)-7-fluoro-12,12a-dihydro-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepin-9-one, which was used without further crystallization as the starting material for the Example described hereinafter.
後処理
- concentrationsubsequently concentrated
- wash30 ml of 4N hydrochloric acid and the solution was washed three times with methylene chloride
- extractionextracted five times with methylene chloride
- customAfter drying the combined organic solutions
- customevaporating the solvent there
出典と根拠
- ORDレコード
- ord-ce4e73e12da141589acf27493c7b03c5
- 出典データセット
- uspto-grants-1997_09
- 特許番号
- US05665718
反応ノート
読み込み中…